Author Archives: Austin Angelo

Analysts Offer Insights on Healthcare Companies: TherapeuticsMD (NASDAQ: TXMD) and Aurinia Pharmaceuticals (NASDAQ: AUPH)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TherapeuticsMD (TXMD – Research Report) and Aurinia Pharmaceuticals (AUPH – Research Report) with bullish sentiments. TherapeuticsMD (TXMD) In a report released yesterday,

Drone Delivery Canada (TAKOF) Receives a Buy from Canaccord Genuity

Canaccord Genuity analyst Doug Taylor maintained a Buy rating on Drone Delivery Canada (TAKOF – Research Report) yesterday and set a price target of C$1.60. The company’s shares closed last Monday at $0.46. According to TipRanks.com, Taylor is ranked #644

Ladenburg Thalmann & Co. Keeps Their Buy Rating on Eiger Biopharmaceuticals (EIGR)

Ladenburg Thalmann & Co. analyst Michael Higgins maintained a Buy rating on Eiger Biopharmaceuticals (EIGR – Research Report) today and set a price target of $28.00. The company’s shares closed last Monday at $7.96. According to TipRanks.com, Higgins has 0

Needham Assigns a Hold Rating on Arista Networks (ANET)

Needham analyst Alex Henderson assigned a Hold rating to Arista Networks (ANET – Research Report) today. The company’s shares closed last Monday at $205.05. According to TipRanks.com, Henderson is a 5-star analyst with an average return of 18.8% and a

Oppenheimer Believes Helen Of Troy (NASDAQ: HELE) Still Has Room to Grow

Oppenheimer analyst Rupesh Parikh assigned a Buy rating to Helen Of Troy (HELE – Research Report) today and set a price target of $235.00. The company’s shares closed last Monday at $197.23, close to its 52-week high of $213.30. According

BCB Bancorp (BCBP) Gets a Hold Rating from Piper Sandler

In a report released today, Nicholas Cucharale from Piper Sandler maintained a Hold rating on BCB Bancorp (BCBP – Research Report), with a price target of $8.50. The company’s shares closed last Monday at $8.14, close to its 52-week low